Academy Award-winning actress Halle Berry has embarked on a new journey as a comms executive at San Francisco-based biotech startup, Pendulum Therapeutics. At 56, Berry is ready for her "second act" after seeing great results from using the company's products. Pendulum Therapeutics focuses on probiotic supplements and aims to help manage sugar levels in Type 2 diabetes patients. Founded in 2013, the startup is valued just shy of $300 million and has attracted over $122 million from investors such as Sequoia Capital, the Mayo Clinic, and Johnson and Johnson.
Top image: Pendulum Therapeutics CEO Colleen Cutcliffe with Berry. Courtesy of Pendulum Therapeutics
To read the complete article visit SFist
